Palacios Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Palacios Wealth Management's BMY Position: Q3 2026 in Review
Palacios Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q3 2026, selling an estimated $52.1K and leaving 5,041 shares worth $315K. The position accounts for 0.17% of the portfolio, ranked #57.
Palacios Wealth Management first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $477K in Q1 2025. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Palacios Wealth Management held 5,041 shares of Bristol-Myers Squibb worth $315K as of Q3 2026.
- Palacios Wealth Management sold 825 Bristol-Myers Squibb shares in Q3 2026, an estimated $52.1K.
- Bristol-Myers Squibb made up 0.17% of Palacios Wealth Management's portfolio in Q3 2026, its #57 holding.
- Palacios Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- Palacios Wealth Management's Bristol-Myers Squibb position peaked at $477K in Q1 2025.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Palacios Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.